Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial

医学 脑出血 外科 随机对照试验 临床试验 开颅术 溶栓 麻醉 内科学 蛛网膜下腔出血 心肌梗塞
作者
Daniel F. Hanley,Richard E. Thompson,John Muschelli,Michael Rosenblum,Nichol A. McBee,Karen Lane,Amanda J. Bistran-Hall,Steven W Mayo,Penelope M. Keyl,Dheeraj Gandhi,Tim C. Morgan,Natalie L. Ullman,W. Andrew Mould,Juan Ricardo Carhuapoma,Carlos S. Kase,Wendy Ziai,Carol B. Thompson,Gayane Yenokyan,Emily J. Huang,William C. Broaddus
出处
期刊:Lancet Neurology [Elsevier BV]
卷期号:15 (12): 1228-1237 被引量:411
标识
DOI:10.1016/s1474-4422(16)30234-4
摘要

Craniotomy, according to the results from trials, does not improve functional outcome after intracerebral haemorrhage. Whether minimally invasive catheter evacuation followed by thrombolysis for clot removal is safe and can achieve a good functional outcome is not known. We investigated the safety and efficacy of alteplase, a recombinant tissue plasminogen activator, in combination with minimally invasive surgery (MIS) in patients with intracerebral haemorrhage.MISTIE was an open-label, phase 2 trial that was done in 26 hospitals in the USA, Canada, the UK, and Germany. We used a computer-generated allocation sequence with a block size of four to centrally randomise patients aged 18-80 years with a non-traumatic (spontaneous) intracerebral haemorrhage of 20 mL or higher to standard medical care or image-guided MIS plus alteplase (0·3 mg or 1·0 mg every 8 h for up to nine doses) to remove clots using surgical aspiration followed by alteplase clot irrigation. Primary outcomes were all safety outcomes: 30 day mortality, 7 day procedure-related mortality, 72 h symptomatic bleeding, and 30 day brain infections. This trial is registered with ClinicalTrials.gov, number NCT00224770.Between Feb 2, 2006, and April 8, 2013, 96 patients were randomly allocated and completed follow-up: 54 (56%) in the MIS plus alteplase group and 42 (44%) in the standard medical care group. The primary outcomes did not differ between the standard medical care and MIS plus alteplase groups: 30 day mortality (four [9·5%, 95% CI 2·7-22.6] vs eight [14·8%, 6·6-27·1], p=0·542), 7 day mortality (zero [0%, 0-8·4] vs one [1·9%, 0·1-9·9], p=0·562), symptomatic bleeding (one [2·4%, 0·1-12·6] vs five [9·3%, 3·1-20·3], p=0·226), and brain bacterial infections (one [2·4%, 0·1-12·6] vs zero [0%, 0-6·6], p=0·438). Asymptomatic haemorrhages were more common in the MIS plus alteplase group than in the standard medical care group (12 [22·2%; 95% CI 12·0-35·6] vs three [7·1%; 1·5-19·5]; p=0·051).MIS plus alteplase seems to be safe in patients with intracerebral haemorrhage, but increased asymptomatic bleeding is a major cautionary finding. These results, if replicable, could lead to the addition of surgical management as a therapeutic strategy for intracerebral haemorrhage.National Institute of Neurological Disorders and Stroke, Genentech, and Codman.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Akim的应助被瀛洲晚风采纳,获得10
1秒前
糟糕的爆米花完成签到,获得积分10
1秒前
1秒前
无情麦片发布了新的文献求助30
1秒前
2秒前
Bob完成签到 ,获得积分10
2秒前
乐乐的应助被sxnyyy采纳,获得10
2秒前
汉堡包的应助被sxnyyy采纳,获得10
2秒前
SciGPT的应助被俏皮的沉鱼采纳,获得10
2秒前
2秒前
这波你的吗完成签到 ,获得积分10
3秒前
刘晨发布了新的文献求助10
3秒前
xucc发布了新的文献求助10
3秒前
在水一方的应助被syh采纳,获得10
3秒前
4秒前
王博龙完成签到,获得积分10
4秒前
5秒前
腼腆的眼睛完成签到 ,获得积分10
5秒前
hana发布了新的文献求助10
5秒前
5秒前
东方完成签到,获得积分10
5秒前
丘比特的应助被苦瓜大王采纳,获得10
5秒前
5秒前
liuis完成签到,获得积分10
6秒前
6秒前
Jasper的应助被一滩烂泥采纳,获得10
6秒前
Lotus完成签到,获得积分10
6秒前
洞洞幺发布了新的文献求助10
6秒前
大绿豆cc发布了新的文献求助10
6秒前
7秒前
忱麓裔发布了新的文献求助10
7秒前
9秒前
ke完成签到,获得积分10
9秒前
Jupiter发布了新的文献求助10
9秒前
9秒前
ypz发布了新的文献求助10
9秒前
雨天完成签到,获得积分10
9秒前
Overlap完成签到 ,获得积分10
9秒前
靓丽芙蓉完成签到,获得积分10
9秒前
islazheng发布了新的文献求助10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175707
求助须知:如何正确求助?哪些是违规求助? 9567353
关于积分的说明 21792214
捐赠科研通 7770334
什么是DOI,文献DOI怎么找? 3431908
关于科研通互助平台的介绍 2556260
邀请新用户注册赠送积分活动 2477417